LPLinda Popella

Linda Popella

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Linda Popella has a total of 34 co-authors. Here are the top co-authors by number of shared publications:

  • Jörg Vogel

    University of Würzburg

    8 shared publications
  • Lars Barquist

    Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI)

    5 shared publications
  • Svetlana Ðurica-Mitić

    Institute of Molecular Infection Biology, University of Würzburg, Würzburg, Germany

    3 shared publications
  • Adam J. Mulkern

    Institute for Molecular Bacteriology, TWINCORE Centre for Experimental and Clinical Infection Research, a joint venture between the Hannover Medical School (MHH) and the Helmholtz Centre for Infection Research (HZI), Hannover, Germany

    2 shared publications
  • Chandradhish Ghosh

    Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI) , D-97080 Würzburg

    2 shared publications
  • Marco Galardini

    Institute for Molecular Bacteriology, TWINCORE Centre for Experimental and Clinical Infection Research, a joint venture between the Hannover Medical School (MHH) and the Helmholtz Centre for Infection Research (HZI), Hannover, Germany

    2 shared publications

Latest Publications

  • Open Access

    A systematic identification of resistance determinants to antisense antibiotics suggests adaptation strategies dependent on the delivery peptide

    by Adam J. Mulkern, Thu-Hien Vu, Linda Popella, Tobias Kerrinnes, Svetlana Ðurica-Mitić, Manuel Halte, Kylee Dresbach-Hill, Anne-Catrin Uhlemann, Stephan Uphoff, Lars Barquist, et al.

    The rise of antimicrobial resistance (AMR) among human pathogens is a serious threat to global health, demanding novel treatment strategies. Antibiotics based on programmable antisense oligomers (asobiotics) offer an attractive solution, as their specificity can be quickly updated to target resistant bacteria. To understand the genetic architecture of resistance to asobiotics, we used laboratory evolution assays to identify mutations that decrease susceptibility to antisense peptide nucleic acids (PNAs) in four major gram-negative pathogens: Escherichia coli , Klebsiella pneumoniae , Salmonella enterica , and Pseudomonas aeruginosa . Reduced susceptibility depended on the cell-penetrating peptide (CPP) conjugated to the PNA, with reduced uptake emerging as a common adaptation only against the (KFF) 3 -K CPP. Accordingly, sbmA was consistently mutated across all species treated with (KFF) 3 -K-conjugated PNAs. We further identified mutations related to translation, peptide transport, and the cell envelope, generating new hypotheses on the cellular response to CPP-PNA conjugates. By contrast, for (RXR) 4 XB- acpP we observed only a modest resistance increase, driven by mutations in the PNA binding site that could be readily bypassed by changing the PNA sequence. These findings show that CPP identity strongly determines robustness against resistance evolution, and that laboratory evolution can illuminate the mechanisms of action of asobiotics.

  • Open Access

    Programmable antisense oligomers for phage functional genomics

    by Milan Gerovac, Leandro Buhlmann, Yan Zhu, Svetlana Ðurica-Mitić, Valentin Rech, Samuel Carien, Tom Gräfenhan, Linda Popella, Jörg Vogel

    Bacteriophages are the most abundant entities on earth and exhibit vast genetic and phenotypic diversity. Exploitation of this largely unexplored molecular space requires identification and functional characterization of genes that act at the phage–host interface. So far, this has been restricted to few model phage–host systems that are amenable to genetic manipulation. Here, to overcome this limitation, we introduce a non-genetic mRNA targeting approach using exogenous delivery of programmable antisense oligomers to silence genes of DNA and RNA phages. A systematic knockdown screen of core and accessory genes of the nucleus-forming jumbo phage ΦKZ, coupled to RNA-sequencing and microscopy analyses, reveals previously unrecognized proteins that are essential for phage propagation and that, upon silencing, elicit distinct phenotypes at the level of the phage and host response. One of these factors is the RNase H-like protein ΦKZ155 (also known as Nlp2), which acts at a major decision point during infection, linking the formation of the protective phage nucleus to phage genome amplification. This non-genetic antisense oligomer-based gene silencing method promises to be a versatile tool for molecular discovery in phage biology, will help to elucidate defence and anti-defence mechanisms in non-model phage–host pairs, and offers potential for optimizing phage therapy and biotechnological procedures.


  • Open Access

    High‐Throughput Tiling of Essential mRNAs Increases Potency of Antisense Antibiotics

    by Giorgia Danti, Linda Popella, Jörg Vogel, Hans M. Maric

    Antimicrobial resistance is outpacing drug discovery, creating an urgent need for precision‐based strategies to counteract resistant pathogens. Peptide nucleic acid (PNA)‐based antisense molecules offer a promising approach by selectively inhibiting essential bacterial mRNAs, but their design rules for optimal efficacy remain incompletely understood. Here, a scalable high‐throughput platform is developed for the nanomolar‐scale one‐shot synthesis of PNAs as carrier peptide conjugates (PPNAs). Parallel synthesis of up to 1,536 PPNAs composed of up to 21 PNA or peptide building blocks enabled systematic, base‐by‐base analysis of RNA hybridization, mRNA inhibition, and antimicrobial activity across nine essential genes in uropathogenic Escherichia coli. The accuracy and robustness of this high‐throughput tiling platform are demonstrated through in‐depth analysis of the acpP mRNA and identify potent antisense inhibitors of rpsH, ftsZ, and murA. This approach provides an efficient and scalable route to design and optimize PNA‐based antimicrobials, facilitating empirical testing across diverse bacterial targets. By enabling large‐scale exploration of the relevant mRNA sequence space, the sequence tiling platform accelerates the discovery of antisense‐based antimicrobials, offering a scalable strategy to develop precision therapies against various pathogens and combat resistance.


  • Open Access

    An antisense oligomer conjugate with unpredicted bactericidal activity against Fusobacterium nucleatum

    by Valentina Cosi, Jakob Jung, Linda Popella, Falk Ponath, Chandradhish Ghosh, Lars Barquist, Jörg Vogel

    Fusobacteria are commensal members of the oral microbiome that can spread from their primary niche and colonize distal sites in the human body. Their enrichment in colorectal and breast cancer tissue has been associated with tumor growth, metastasis, and chemotherapeutic resistance. The use of non-selective antibiotics to remove fusobacteria impairs tumor progression, but prolonged application risks side effects such as gastrointestinal problems and dysbiosis. Species-specific antisense antibiotics based on peptide nucleic acid (PNA) have shown efficacy in many Gram-negative species, suggesting that antisense PNAs may also enable a tailored depletion of fusobacteria. Here, we have investigated the antibacterial potential of cell-penetrating peptide (CPP)-PNA conjugates targeting the mRNA of putative essential genes in Fusobacterium nucleatum . Unexpectedly, we observed no growth inhibition with any of the target-specific PNAs, but identified a non-targeting control CPP-PNA (FUS79, (RXR) 4 XB-GACATAATTGT) as a potent growth inhibitor of F. nucleatum . Our data suggest that the CPP and specific sequence features of FUS79 are responsible for its activity, rather than an antisense effect. Interestingly, FUS79 also inhibits the growth of five additional fusobacterial strains but not of F. nucleatum ssp. vincentii (FNV). RNA-seq analysis indicates that FUS79 induces a membrane stress response in a vulnerable F. nucleatum strain but not in FNV. Collectively, our attempt at developing antisense antibiotics for fusobacteria discovers a potent growth inhibitor, whose bactericidal effect appears independent of target-specific mRNA inhibition. IMPORTANCE: Enrichment of F. nucleatum at cancer sites is associated with increased tumor growth and metastasis. Antibiotic treatment to remove the bacteria was shown to change the course of cancer progression. Here we explore first steps to establish peptide nucleic acids (PNAs) as specific antisense antibiotics, thereby laying the foundation for further development of antisense technology in fusobacteria. While the CPP-PNA FUS79 was initially designed as a control, we observed that the compound was bactericidal for specific fusobacterial strains. Our results suggest that FUS79 might be able to selectively deplete fusobacterial strains from bacterial communities, offering a new perspective on fusobacterial removal at the tumor site.

  • Open Access

    ASOBIOTICS 2024: an interdisciplinary symposium on antisense-based programmable RNA antibiotics

    by Jörg Vogel, Franziska Faber, Lars Barquist, Anke Sparmann, Linda Popella, Chandradhish Ghosh

    The international symposium ASOBIOTICS 2024 brought together scientists across disciplines to discuss the challenges of advancing antibacterial antisense oligomers (ASOs) from basic research to clinical application. Hosted by the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg, Germany, on September 12–13, 2024, the event featured presentations covering major milestones and current challenges of this antimicrobial technology and its applications against pathogens, commensals, and bacterial viruses. General design principles and modification of ASOs based on peptide nucleic acid (PNA) or phosphorodiamidate-morpholino-oligomer (PMO) chemistry, promising cellular RNA targets, new delivery technologies, as well as putative resistance mechanisms, were discussed. A panel discussion noted the challenge of nomenclature: antibacterial ASOs lack a single, universally used name. To address this, the term “asobiotics” was proposed to unite a community of like-minded scientists that are committed to advancing ASOs as antimicrobials. A consistent name will simplify literature searches and help scientists and funders appreciate the potential of programmable RNA antibiotics to combat antimicrobial resistance and enable precise microbiome editing.


  • Open Access

    A systematic identification of resistance determinants to antisense antibiotics suggests adaptation strategies dependent on the delivery peptide

    by Adam J. Mulkern, Thu-Hien Vu, Linda Popella, Tobias Kerrinnes, Svetlana Ðurica-Mitić, Lars Barquist, Jörg Vogel, Marco Galardini

    The rise of antimicrobial resistance (AMR) among human pathogenic microbes is a serious threat to global health, calling for the development of novel treatment strategies. Antibiotics based on programmable antisense oligomers (asobiotics) offer an attractive solution to the “arms-race”, as their specificity can be quickly updated and tailored to target resistant bacteria. In order to understand the genetic architecture of resistance to asobiotics, we employed laboratory evolution assays to identify mutations that decrease susceptibility to antisense peptide nucleic acid (PNA) against four major gram-negative pathogens: Escherichia coli, Klebsiella pneumoniae, Salmonella enterica , and Pseudomonas aeruginosa . We observed that the reduction in susceptibility upon asobiotics treatment was dependent on the specific cell penetrating peptide (CPP) being conjugated to the PNAs, suggesting that reduced uptake is a common adaptation strategy only against the (KFF) 3 -K CPP. We in fact observed that sbmA was frequently mutated in all tested species when treated with (KFF) 3 -K conjugated PNAs. We further identified mutations related to translation, peptide transport and cell envelope, which provide new hypotheses on cellular response to CPP-PNAs conjugates. Furthermore, for (RXR) 4 XB- acpP we observed a modest increase in resistance only when mutations in the PNA binding site were induced, which could easily be bypassed by changing the PNA sequence. These findings indicate that the specific identity of the CPP used plays a key role in determining its robustness against the evolution of resistance, and that laboratory evolution can illuminate the remaining gaps in our knowledge on the mechanisms of action of asobiotics.


  • Open Access

    Non-genetic messenger RNA silencing reveals essential genes in phage-host interplay

    by Milan Gerovac, Svetlana Ðurica-Mitić, Leandro Buhlmann, Valentin Rech, Yan Zhu, Samuel Carien, Linda Popella, Jörg Vogel

    Bacteriophages are the most abundant entities on earth and exhibit vast genetic and phenotypic diversity. Exploitation of this largely unexplored molecular space requires identification and functional characterisation of genes that act at the phage-host interface. To date, this is restricted to few model phage-host systems that are amenable to genetic manipulation. To overcome this limitation, we introduce a non-genetic mRNA targeting approach using exogenous delivery of programmable antisense oligomers (ASOs) to silence genes of both DNA and RNA phages. A systematic knockdown screen of core and accessory genes of the nucleus-forming jumbo phage ΦKZ, coupled to RNA-sequencing and microscopy analyses, reveals previously unrecognised proteins that are essential for phage replication and that, upon silencing, elicit distinct phenotypes at the level of the phage and host response. One of these factors is a ΦKZ-encoded nuclease that acts at a major decision point during infection, linking the formation of the protective phage nucleus to phage genome amplification. The non-genetic ASO-based gene silencing used here promises to be a versatile tool for molecular discovery in phage biology, will help elucidate defence and anti-defence mechanisms in non-model phage-host pairs, and offers potential for optimising phage therapy and biotechnological procedures.


  • Open Access

    Improved RNA stability estimation through Bayesian modeling reveals most Salmonella transcripts have subminute half-lives

    by Laura Jenniches, Charlotte Michaux, Linda Popella, Sarah Reichardt, Jörg Vogel, Alexander J. Westermann, Lars Barquist

    RNA decay is a crucial mechanism for regulating gene expression in response to environmental stresses. In bacteria, RNA-binding proteins (RBPs) are known to be involved in posttranscriptional regulation, but their global impact on RNA half-lives has not been extensively studied. To shed light on the role of the major RBPs ProQ and CspC/E in maintaining RNA stability, we performed RNA sequencing of Salmonella enterica over a time course following treatment with the transcription initiation inhibitor rifampicin (RIF-seq) in the presence and absence of these RBPs. We developed a hierarchical Bayesian model that corrects for confounding factors in rifampicin RNA stability assays and enables us to identify differentially decaying transcripts transcriptome-wide. Our analysis revealed that the median RNA half-life in Salmonella in early stationary phase is less than 1 min, a third of previous estimates. We found that over half of the 500 most long-lived transcripts are bound by at least one major RBP, suggesting a general role for RBPs in shaping the transcriptome. Integrating differential stability estimates with cross-linking and immunoprecipitation followed by RNA sequencing (CLIP-seq) revealed that approximately 30% of transcripts with ProQ binding sites and more than 40% with CspC/E binding sites in coding or 3′ untranslated regions decay differentially in the absence of the respective RBP. Analysis of differentially destabilized transcripts identified a role for ProQ in the oxidative stress response. Our findings provide insights into posttranscriptional regulation by ProQ and CspC/E, and the importance of RBPs in regulating gene expression.